ORBIMED ADVISORS LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   < prev 1 ... 2 3 4 5 6 7 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.6410,18216,6980
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.73921590
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.739,64216,6810
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.05771580
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.058,09716,5990
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.591893010
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.5919,81131,4990
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.62971570
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.6210,18016,4920
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.94831610
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.948,71716,9110
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.62631650
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.626,65417,4330
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM3.00501500
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM3.005,22715,6810
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.002595180
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.0027,24154,4820
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS5.701,3927,93465,39866.8 K to 65.4 K (-2.08 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS5.70146,243833,5857,194,2227.3 M to 7.2 M (-1.99 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM5.644726566,79066.7 K to 66.8 K (+0.07 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM5.644,97128,0367,340,4657.3 M to 7.3 M (+0.07 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.329923066,74366.6 K to 66.7 K (+0.15 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.3210,44724,2377,335,4947.3 M to 7.3 M (+0.14 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.019719566,64466.5 K to 66.6 K (+0.15 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.0110,21620,5347,325,0477.3 M to 7.3 M (+0.14 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.0114228566,54766.4 K to 66.5 K (+0.21 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.0114,85829,8657,314,8317.3 M to 7.3 M (+0.20 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.649715966,40566.3 K to 66.4 K (+0.15 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.6410,18216,6987,299,9737.3 M to 7.3 M (+0.14 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.739215966,30866.2 K to 66.3 K (+0.14 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.739,64216,6817,289,7917.3 M to 7.3 M (+0.13 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.057715866,21666.1 K to 66.2 K (+0.12 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.058,09716,5997,280,1497.3 M to 7.3 M (+0.11 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.5918930166,13966 K to 66.1 K (+0.29 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.5919,81131,4997,272,0527.3 M to 7.3 M (+0.27 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.629715765,95065.9 K to 66 K (+0.15 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.6210,18016,4927,252,2417.2 M to 7.3 M (+0.14 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.948316165,85365.8 K to 65.9 K (+0.13 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM1.948,71716,9117,242,0617.2 M to 7.2 M (+0.12 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.626316565,77065.7 K to 65.8 K (+0.10 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.626,65417,4337,233,3447.2 M to 7.2 M (+0.09 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM3.005015065,70765.7 K to 65.7 K (+0.08 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM3.005,22715,6817,226,6907.2 M to 7.2 M (+0.07 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.0025951865,65765.4 K to 65.7 K (+0.40 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM2.0027,24154,4827,221,4637.2 M to 7.2 M (+0.38 %)
Dec 12 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS82.50250,00020,625,000941,0001.2 M to 941 K (-20.99 %)
Nov 27 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS75.00267,00020,025,0001,191,0001.5 M to 1.2 M (-18.31 %)
Nov 21 2017SCPHscPharmaceuticals ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.0018,500,00000
Nov 21 2017SCPHscPharmaceuticals ...ORBIMED ADVISORS LLC10% OwnerBuyP14.00833,33311,666,6623,409,8652.6 M to 3.4 M (+32.34 %)
Nov 21 2017SCPHscPharmaceuticals ...ORBIMED ADVISORS LLC10% OwnerBuyC0.002,576,53202,576,5320 to 2.6 M
Nov 20 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS76.238,377638,5791,458,0001.5 M to 1.5 M (-0.57 %)
Nov 20 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS75.3771,5985,396,3411,466,3771.5 M to 1.5 M (-4.66 %)
Nov 20 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS74.49100,0457,452,3521,537,9751.6 M to 1.5 M (-6.11 %)
Nov 20 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS73.4843,3003,181,6841,638,0201.7 M to 1.6 M (-2.58 %)
Nov 20 2017LOXOLoxo Oncology, Inc ...ORBIMED ADVISORS LLCDirectorSellS72.4646,6803,382,4331,681,3201.7 M to 1.7 M (-2.70 %)
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.002,232,01400
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.00229,41200
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.00736,64800
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.00704,84600
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.0066,66700
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerBuyC10.00500,0005,000,0001,868,9661.4 M to 1.9 M (+36.52 %)
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerBuyC0.00653,97401,368,966715 K to 1.4 M (+91.47 %)
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerBuyC0.00114,3200714,992600.7 K to 715 K (+19.03 %)
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerBuyC0.00328,9090600,672271.8 K to 600.7 K (+121.03 %)
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerBuyC0.00252,2300271,76319.5 K to 271.8 K (+1,291.30 %)
Nov 20 2017ASNSArsanis, Inc.ORBIMED ADVISORS LLC10% OwnerBuyC0.0019,533019,5330 to 19.5 K
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.002,546,29500
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyP17.00355,0006,035,0002,901,2952.5 M to 2.9 M (+13.94 %)
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyC0.002,546,29502,546,2950 to 2.5 M
Oct 05 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.681,8991,29101.9 K to 0 (-100.00 %)
Oct 05 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.68199,718135,8080199.7 K to 0 (-100.00 %)
Oct 02 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.748886571,8992.8 K to 1.9 K (-31.86 %)
Oct 02 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.7493,24669,002199,718293 K to 199.7 K (-31.83 %)
Oct 02 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.723,5922,5862,7876.4 K to 2.8 K (-56.31 %)
Oct 02 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.72376,950271,404292,964669.9 K to 293 K (-56.27 %)
Sep 29 2017BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS28.25672,00018,984,0004,129,6384.8 M to 4.1 M (-14.00 %)
Sep 28 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.924984586,3796.9 K to 6.4 K (-7.24 %)
Sep 28 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS0.9252,30148,117669,914722.2 K to 669.9 K (-7.24 %)
Sep 28 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.037067276,8777.6 K to 6.9 K (-9.31 %)
Sep 28 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.0374,09676,319722,215796.3 K to 722.2 K (-9.30 %)
Sep 11 2017BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseX15.035,00075,1500
Sep 11 2017BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS22.355,000111,7504,801,6384.8 M to 4.8 M (-0.10 %)
Sep 11 2017BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerBuyX15.035,00075,1504,806,6384.8 M to 4.8 M (+0.10 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS40.7755322,5467,8958.4 K to 7.9 K (-6.55 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS40.7758,0472,366,576828,605886.7 K to 828.6 K (-6.55 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS39.631,80871,6518,44810.3 K to 8.4 K (-17.63 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS39.63189,7927,521,457886,6521.1 M to 886.7 K (-17.63 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.941,65162,63910,25611.9 K to 10.3 K (-13.87 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.94173,3496,576,8611,076,4441.2 M to 1.1 M (-13.87 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.721,03839,15311,90712.9 K to 11.9 K (-8.02 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.72109,0404,112,9891,249,7931.4 M to 1.2 M (-8.02 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.8242416,03612,94513.4 K to 12.9 K (-3.17 %)
Sep 05 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.8244,4981,682,9141,358,8331.4 M to 1.4 M (-3.17 %)
Aug 25 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.501251887,5837.7 K to 7.6 K (-1.62 %)
Aug 25 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.5013,07519,613796,311809.4 K to 796.3 K (-1.62 %)
Aug 25 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.5010157,7087.7 K to 7.7 K (-0.13 %)
Aug 25 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.501,0901,635809,386810.5 K to 809.4 K (-0.13 %)
Aug 22 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.5252797,7187.8 K to 7.7 K (-0.67 %)
Aug 22 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.525,4488,281810,476815.9 K to 810.5 K (-0.67 %)
Aug 22 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.4928427,7707.8 K to 7.8 K (-0.36 %)
Aug 22 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.492,9524,398815,924818.9 K to 815.9 K (-0.36 %)
Aug 22 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.526309587,7988.4 K to 7.8 K (-7.48 %)
Aug 22 2017ROKARoka BioScience, I ...ORBIMED ADVISORS LLC10% OwnerSellS1.5266,166100,572818,876885 K to 818.9 K (-7.48 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.852,14080,99913,36915.5 K to 13.4 K (-13.80 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS37.85224,7808,507,9231,403,3311.6 M to 1.4 M (-13.81 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.0161923,52815,50916.1 K to 15.5 K (-3.84 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.0164,9612,469,1681,628,1111.7 M to 1.6 M (-3.84 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.2930711,75516,12816.4 K to 16.1 K (-1.87 %)
Aug 17 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS38.2932,1931,232,6701,693,0721.7 M to 1.7 M (-1.87 %)
Jul 27 2017KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.0010,707,98500
Jul 27 2017KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP15.00319,3334,789,9952,375,2792.1 M to 2.4 M (+15.53 %)
Jul 27 2017KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyC0.002,055,94602,055,9460 to 2.1 M
Jul 26 2017NVLSALPINE IMMUNE SCIE ...ORBIMED ADVISORS LLCDirectorGrantA0.003,298,51603,298,5160 to 3.3 M
Jun 15 2017CTICCTI BIOPHARMA CORPORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.007,50000
Jun 15 2017CTICCTI BIOPHARMA CORPORBIMED ADVISORS LLC10% OwnerBuyC0.005,000,00005,000,0000 to 5 M
Apr 27 2017STDYSteadyMed Ltd.ORBIMED ADVISORS LLC10% OwnerOption ExerciseP0.00293,5000293,500
Apr 27 2017STDYSteadyMed Ltd.ORBIMED ADVISORS LLC10% OwnerOption ExerciseP0.00293,5000293,500
Apr 27 2017STDYSteadyMed Ltd.ORBIMED ADVISORS LLC10% OwnerBuyP5.90587,0003,463,3002,123,0981.5 M to 2.1 M (+38.21 %)
Apr 27 2017STDYSteadyMed Ltd.ORBIMED ADVISORS LLC10% OwnerBuyP5.90587,0003,463,3002,123,0981.5 M to 2.1 M (+38.21 %)
Mar 28 2017ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorBuyP4.201,190,4764,999,9996,149,3775 M to 6.1 M (+24.01 %)
Mar 17 2017ZETAIIAerpio Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP5.00762,9953,814,9754,416,4463.7 M to 4.4 M (+20.88 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS44.5469931,13316,43517.1 K to 16.4 K (-4.08 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS44.5473,4013,269,2811,725,2651.8 M to 1.7 M (-4.08 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS46.13732317,13417.1 K to 17.1 K (-0.04 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS46.1369331,9681,798,6661.8 M to 1.8 M (-0.04 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.301,99890,50917,14119.1 K to 17.1 K (-10.44 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.30208,7129,454,6541,799,3592 M to 1.8 M (-10.39 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.9891542,07219,12920 K to 19.1 K (-4.56 %)
Mar 14 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS45.9896,1134,419,2762,008,0712.1 M to 2 M (-4.57 %)
Mar 07 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS47.0552624,74820,04420.6 K to 20 K (-2.56 %)
Mar 07 2017GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS47.0555,2462,599,3242,104,1842.2 M to 2.1 M (-2.56 %)
Feb 21 2017AGLEAeglea BioTherapeu ...ORBIMED ADVISORS LLC10% OwnerBuyP5.367,00037,5201,469,5241.5 M to 1.5 M (+0.48 %)
Feb 21 2017AGLEAeglea BioTherapeu ...ORBIMED ADVISORS LLC10% OwnerBuyP5.1971,800372,6421,462,5241.4 M to 1.5 M (+5.16 %)
Feb 21 2017AGLEAeglea BioTherapeu ...ORBIMED ADVISORS LLC10% OwnerBuyP5.0430,500153,7201,390,7241.4 M to 1.4 M (+2.24 %)
Jan 20 2017VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorOption ExerciseP3.176231,9753,843
Jan 20 2017VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorOption ExerciseP3.1765,491207,606403,692
Jan 20 2017VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorBuyP3.003,1189,35489,22586.1 K to 89.2 K (+3.62 %)
Jan 20 2017VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorBuyP3.00327,459982,3779,369,3429 M to 9.4 M (+3.62 %)
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...ORBIMED ADVISORS LLCDirectorSellJ0.002,149,902002.1 M to 0 (-100.00 %)
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...ORBIMED ADVISORS LLCDirectorSellJ0.0034,2910034.3 K to 0 (-100.00 %)
Dec 01 2016RPBIFRESPONSE BIOMEDICA ...ORBIMED ADVISORS LLCDirectorSellJ0.003,604,266003.6 M to 0 (-100.00 %)
Sep 23 2016ROKARoka BioScience, I ...ORBIMED ADVISORS LLCDirectorOption ExerciseP0.0053,909053,909
Sep 23 2016ROKARoka BioScience, I ...ORBIMED ADVISORS LLCDirectorOption ExerciseP0.005,660,37705,660,377
Sep 23 2016ROKARoka BioScience, I ...ORBIMED ADVISORS LLCDirectorOption ExerciseP0.0038038
Sep 23 2016ROKARoka BioScience, I ...ORBIMED ADVISORS LLCDirectorOption ExerciseP0.003,96203,962
Aug 24 2016VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorOption ExerciseP2.953,2209,4993,220
Aug 24 2016VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorOption ExerciseP2.95338,201997,693338,201
Aug 24 2016VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorBuyP2.9510,73631,67186,10775.4 K to 86.1 K (+14.24 %)
Aug 24 2016VRAYViewRay, Inc.ORBIMED ADVISORS LLCDirectorBuyP2.951,127,3383,325,6479,041,8837.9 M to 9 M (+14.24 %)
Aug 12 2016GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.721334,48520,57020.7 K to 20.6 K (-0.64 %)

Page:   < prev 1 ... 2 3 4 5 6 7 next >

Contact us | Follow us on Twitter